This poster was presented at ISPOR EU, 2026. It characterises real-world corticosteroid prescribing and cumulative steroid exposure in people with myasthenia gravis treated with novel biological therapies.
See here for more of our publications.
This poster was presented at ISPOR EU, 2026. It characterises real-world corticosteroid prescribing and cumulative steroid exposure in people with myasthenia gravis treated with novel biological therapies.
See here for more of our publications.
Join us and receive white papers as they are published.